Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 600 clinical trials
None
68Ga-DOTA-TATE PET/CT Imaging in NETs

This clinical trial is a pragmatic study aiming to evaluate the innocuity/safety profile of the PET radiotracer 68Ga-DOTA-TATE, and to establish the procedure as a routine standard-of-care diagnostic tool for all neuro-endocrine cancer patients. It is a single-center study, but with recruitment across all Canada. The trial is prospective, non-randomized, …

  • 0 views
  • 08 May, 2021
  • 1 location
None
PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer

Through the conduct of a Phase III randomized controlled trial, investigators plan to: 1) determine if PSMA PET/CT guided intensification of radiotherapy or surgery improves cancer outcomes

  • 0 views
  • 01 Dec, 2021
  • 3 locations
None
68Ga-PSMA-11 PET/CT in Patients With Various Types of Cancer

To evaluate the potential usefulness of 68Ga-PSMA-11 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions, efficacy assessment and

  • 0 views
  • 11 Apr, 2021
  • 1 location
None
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Using PET/CT Imaging

/computed tomography (PET/CT), may help doctors look for cancer that has spread to the pelvis. Androgens can cause the growth of prostate cancer cells. Apalutamide may help fight prostate cancer by blocking

stereotactic body radiation therapy
metastasis
androgens
cancer
ct scan
  • 0 views
  • 19 Nov, 2021
  • 3 locations
None
Dutch National Randomized Study: PSMA-PET/CT as a Triage Tool for Pelvic Lymph Node Dissection in Prostatectomy Patients

To determine if the use of Prostate-Specific Membrane Antigen Positron Emission Computer Tomography (PSMA PET/CT) as a selection tool for performing extended lymph node dissection (ePLND) for

  • 0 views
  • 25 Aug, 2021
  • 1 location
None
Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence

This study evaluates the value of Gallium-68 labeled PSMA (68Ga-PSMA) for PET/CT imaging of prostate cancer recurrence. 68Ga-PSMA is a radioactive molecule, which binds to prostate cancer cells

definitive treatment
gallium ga 68-labeled psma-11
cancer
ct scan
adenocarcinoma
  • 0 views
  • 19 Feb, 2021
  • 1 location
None
F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets

The primary objective is to compare the diagnostic performance of 18F- Fluoride PET/CT scanning to that of conventional bone scanning for detecting cancer that has spread to the bone

cancer
metastasis
bone scan
  • 210 views
  • 07 Nov, 2020
  • 12 locations
None
Positron Emission Tomography (PET)/Computed Tomography (CT) and Roentgen in Lung Cancer: Evaluation of Patients in General Practice

examination ceases. PET/CT has a higher sensitivity (96 %), than chest x-ray. In the latter years only little improvement in the survival rate of lung cancer has been made. Screening studies is

x-rays
ct scan
  • 25 views
  • 07 Nov, 2020
  • 2 locations
None
PSMA PET Imaging of Recurrent Prostate Cancer

The purpose of this study is to see if a new diagnostic research agent named 68Ga-HBED-CC-PSMA can show prostate cancer on a PET/CT scan that cannot be seen on other standard imaging even when

gallium ga 68-labeled psma-11
recurrent prostate cancer
cancer
ct scan
adenocarcinoma
  • 7 views
  • 27 Jan, 2021
  • 8 locations
None
Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma

> Hypothesis: The radiation dose and treatment volume can be safely reduced from 30 Gy to 20 Gy while maintaining high rates of local control in patients who had a negative PET-CT scan following rituximab

chemoimmunotherapy
b-cell lymphoma
ct scan
hodgkin's disease
anthracyclines
  • 8 views
  • 01 Aug, 2021
  • 13 locations